IL-9 is a Th17-derived cytokine that limits pathogenic activity in organ-specific autoimmune disease

European Journal of Immunology

Volumn 41, Issue 4, 2011, Pages 952-962

  Stephens, Geoffrey L ^a   Swerdlow, Bonnie ^a   Benjamin, Ebony ^a   Coyle, Anthony J ^a,b   Humbles, Alison ^a   Kolbeck, Roland ^a   Fung, Michael ^a  

^a MEDIMMUNE   (United States)

^b PFIZER INC   (United States)

Author keywords

Autoimmunity; Gastritis; Human; IL 9; Th17

Indexed keywords

INTERLEUKIN 9;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CELL SURVIVAL; CYTOKINE PRODUCTION; DISEASE SEVERITY; GASTRITIS; HUMAN; HUMAN CELL; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH17 CELL;

ANIMALS; AUTOCRINE COMMUNICATION; AUTOIMMUNE DISEASES; CELL DIFFERENTIATION; CELL SURVIVAL; CELLS, CULTURED; GASTRITIS; HUMANS; IMMUNOLOGIC MEMORY; INTERLEUKIN-9; MICE; MICE, INBRED BALB C; ORGAN SPECIFICITY; TH17 CELLS;

EID: 79953036874     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201040879     Document Type: Article

References (49)

1. Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M. and Stockinger, B., TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006. 24: 179-189.
2. Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M. and Weaver, C. T., Interleukin 17-producing CD4+effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 2005. 6: 1123-1132.
3. Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y. H., Wang, Y. et al., A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 2005. 6: 1133-1141.
4. Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L. and Kuchroo, V. K., Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006. 441: 235-238.
5. Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D. et al., Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 2006. 441: 231-234.
6. Tzartos, J. S., Friese, M. A., Craner, M. J., Palace, J., Newcombe, J., Esiri, M. M. and Fugger, L., Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am. J. Pathol. 2008. 172: 146-155.
7. van Beelen, A. J., Teunissen, M. B., Kapsenberg, M. L. and de Jong, E. C., Interleukin-17 in inflammatory skin disorders. Curr. Opin. Allergy Clin. Immunol. 2007. 7: 374-381.
8. Fujino, S., Andoh, A., Bamba, S., Ogawa, A., Hata, K., Araki, Y., Bamba, T. and Fujiyama, Y., Increased expression of interleukin 17 in inflammatory bowel disease. Gut 2003. 52: 65-70.
9. Houssiau, F. A., Renauld, J. C., Stevens, M., Lehmann, F., Lethe, B., Coulie, P. G. and Van Snick, J., Human T cell lines and clones respond to IL-9. J. Immunol. 1993. 150: 2634-2640.
10. Kimura, Y., Takeshita, T., Kondo, M., Ishii, N., Nakamura, M., Van Snick, J. and Sugamura, K., Sharing of the IL-2 receptor gamma chain with the functional IL-9 receptor complex. Int. Immunol. 1995. 7: 115-120.
11. Shimbara, A., Christodoulopoulos, P., Soussi-Gounni, A., Olivenstein, R., Nakamura, Y., Levitt, R. C., Nicolaides, N. C. et al., IL-9 and its receptor in allergic and nonallergic lung disease: increased expression in asthma. J. Allergy Clin. Immunol. 2000. 105: 108-115.
12. Zhou, Y., McLane, M. and Levitt, R. C., Th2 cytokines and asthma. Interleukin-9 as a therapeutic target for asthma. Respir. Res. 2001. 2: 80-84.
13. Temann, U. A., Laouar, Y., Eynon, E. E., Homer, R. and Flavell, R. A., IL9 leads to airway inflammation by inducing IL13 expression in airway epithelial cells. Int. Immunol. 2007. 19: 1-10.
14. Soussi-Gounni, A., Kontolemos, M. and Hamid, Q., Role of IL-9 in the pathophysiology of allergic diseases. J. Allergy Clin. Immunol. 2001. 107: 575-582.
15. Soroosh, P. and Doherty, T. A., Th9 and allergic disease. Immunology 2009. 127: 450-458.
16. McNamara, P. S. and Smyth, R. L., Interleukin-9 as a possible therapeutic target in both asthma and chronic obstructive airways disease. Drug News Perspect. 2005. 18: 615-621.
17. Kauppi, P., Laitinen, T., Ollikainen, V., Mannila, H., Laitinen, L. A. and Kere, J., The IL9R region contribution in asthma is supported by genetic association in an isolated population. Eur. J. Hum. Genet. 2000. 8: 788-792.
18. Hoyle, G. W. and Brody, A. R., IL-9 and lung fibrosis: a Th2 good guy? Am. J. Respir. Cell Mol. Biol. 2001. 24: 365-367.
19. Hauber, H. P., Bergeron, C. and Hamid, Q., IL-9 in allergic inflammation. Int. Arch. Allergy Immunol. 2004. 134: 79-87.
20. Erpenbeck, V. J., Hohlfeld, J. M., Discher, M., Krentel, H., Hagenberg, A., Braun, A. and Krug, N., Increased expression of interleukin-9 messenger RNA after segmental allergen challenge in allergic asthmatics. Chest 2003. 123: 370S.
21. Panzner, P., Lafitte, J. J., Tsicopoulos, A., Hamid, Q. and Tulic, M. K., Marked up-regulation of T lymphocytes and expression of interleukin-9 in bronchial biopsies from patients With chronic bronchitis with obstruction. Chest 2003. 124: 1909-1915.
22. Lu, L. F., Lind, E. F., Gondek, D. C., Bennett, K. A., Gleeson, M. W., Pino-Lagos, K., Scott, Z. A. et al., Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 2006. 442: 997-1002.
23. Nowak, E. C., Weaver, C. T., Turner, H., Begum-Haque, S., Becher, B., Schreiner, B., Coyle, A. J. et al., IL-9 as a mediator of Th17-driven inflammatory disease. J. Exp. Med. 2009. 206: 1653-1660.
24. Elyaman, W., Bradshaw, E. M., Uyttenhove, C., Dardalhon, V., Awasthi, A., Imitola, J., Bettelli, E. et al., IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+natural regulatory T cells. Proc. Natl. Acad. Sci. USA 2009. 106: 12885-12890.
25. Beriou, G., Bradshaw, E. M., Lozano, E., Costantino, C. M., Hastings, W. D., Orban, T., Elyaman, W. et al., TGF-beta induces IL-9 production from human Th17 Cells. J. Immunol. 2010. 185: 46-54.
26. Veldhoen, M., Uyttenhove, C., Van Snick, J., Helmby, H., Westendorf, A., Buer, J., Martin, B. et al., Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat. Immunol. 2008. 9: 1341-1346.
27. Dardalhon, V., Awasthi, A., Kwon, H., Galileos, G., Gao, W., Sobel, R. A., Mitsdoerffer, M. et al., IL-4 inhibits TGF-beta-induced Foxp3+T cells and, together with TGF-beta, generates IL-9+IL-10+Foxp3(-) effector T cells. Nat. Immunol. 2008. 9: 1347-1355.
28. Jager, A., Dardalhon, V., Sobel, R. A., Bettelli, E. and Kuchroo, V. K., Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J. Immunol. 2009. 183: 7169-7177.
29. Chang, H. C., Sehra, S., Goswami, R., Yao, W., Yu, Q., Stritesky, G. L., Jabeen, R. et al., The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation. Nat. Immunol. 2010. 11: 527-534.
30. Annunziato, F., Cosmi, L., Santarlasci, V., Maggi, L., Liotta, F., Mazzinghi, B., Parente, E. et al., Phenotypic and functional features of human Th17 cells. J. Exp. Med. 2007. 204: 1849-1861.
31. Park, J. H., Yu, Q., Erman, B., Appelbaum, J. S., Montoya-Durango, D., Grimes, H. L. and Singer, A., Suppression of IL7Ralpha transcription by IL-7 and other prosurvival cytokines: a novel mechanism for maximizing IL-7-dependent T cell survival. Immunity 2004. 21: 289-302.
32. Demoulin, J. B., Uyttenhove, C., Van Roost, E., DeLestre, B., Donckers, D., Van Snick, J. and Renauld, J. C., A single tyrosine of the interleukin-9 (IL-9) receptor is required for STAT activation, antiapoptotic activity, and growth regulation by IL-9. Mol. Cell. Biol. 1996. 16: 4710-4716.
33. Stummvoll, G. H., DiPaolo, R. J., Huter, E. N., Davidson, T. S., Glass, D., Ward, J. M. and Shevach, E. M., Th1, Th2, and Th17 effector T cell-induced autoimmune gastritis differs in pathological pattern and in susceptibility to suppression by regulatory T cells. J. Immunol. 2008. 181: 1908-1916.
34. Nurieva, R., Yang, X. O., Chung, Y. and Dong, C., Cutting edge: In vitro generated Th17 cells maintain their cytokine expression program in normal but not lymphopenic hosts. J. Immunol. 2009. 182: 2565-2568.
35. Townsend, M. J., Fallon, P. G., Matthews, D. J., Smith, P., Jolin, H. E. and McKenzie, A. N. J., IL-9-deficient mice establish fundamental roles for IL-9 in pulmonary mastocytosis and goblet cell hyperplasia but not T cell development. Immunity 2000. 13: 573-583.
36. Kopf, M., Le Gros, G., Bachmann, M., Lamers, M. C., Bluethmann, H. and Kohler, G., Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 1993. 362: 245-248.
37. Schmitt, E., Beuscher, H. U., Huels, C., Monteyne, P., van Brandwijk, R., Van Snick, J. and Ruede, E., IL-1 serves as a secondary signal for IL-9 expression. J. Immunol. 1991. 147: 3848-3854.
38. Houssiau, F. A., Schandene, L., Stevens, M., Cambiaso, C., Goldman, M., Van Snick, J. and Renauld, J. C., A cascade of cytokines is responsible for IL-9 expression in human T cells. Involvement of IL-2, IL-4, and IL-10. J. Immunol. 1995. 154: 2624-2630.
39. Wakashin, H., Hirose, K., Iwamoto, I., and Nakajima, H., Role of IL-23-Th17 cell axis in allergic airway inflammation. Int. Arch. Allergy Immunol. 2009. 149: 108-112.
40. McGeachy, M. J., Chen, Y., Tato, C. M., Laurence, A., Joyce-Shaikh, B., Blumenschein, W. M., McClanahan, T. K. et al., The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo. Nat. Immunol. 2009. 10: 314-324.
41. McGeachy, M. J. and Cua, D. J., Th17 cell differentiation: the long and winding road. Immunity 2008. 28: 445-453.
42. McGeachy, M. J. and Cua, D. J., The link between IL-23 and Th17 cell-mediated immune pathologies. Semin. Immunol. 2007. 19: 372-376.
43. Van Snick, J., Goethals, A., Renauld, J. C., Van Roost, E., Uyttenhove, C., Rubira, M. R., Moritz, R. L. and Simpson, R. J., Cloning and characterization of a cDNA for a new mouse T cell growth factor (P40). J. Exp. Med. 1989. 169: 363-368.
44. Uyttenhove, C., Simpson, R. J. and Van Snick, J., Functional and structural characterization of P40, a mouse glycoprotein with T-cell growth factor activity. Proc. Natl. Acad. Sci. USA 1988. 85: 6934-6938.
45. Grohmann, U., Van Snick, J., Campanile, F., Silla, S., Giampietri, A., Vacca, C., Renauld, J. C. et al., IL-9 protects mice from Gram-negative bacterial shock: suppression of TNF-alpha, IL-12, and IFN-gamma, and induction of IL-10. J. Immunol. 2000. 164: 4197-4203.
46. Dodd, J. S., Lum, E., Goulding, J., Muir, R., Van Snick, J. and Openshaw, P. J., IL-9 regulates pathology during primary and memory responses to respiratory syncytial virus infection. J. Immunol. 2009. 183: 7006-7013.
47. Izcue, A., Hue, S., Buonocore, S., rancibia-Carcamo, C. V., Ahern, P. P., Iwakura, Y., Maloy, K. J. and Powrie, F., Interleukin-23 restrains regulatory T cell activity to drive T cell-dependent colitis. Immunity 2008. 28: 559-570.
48. de Vries, V. and Noelle, R. J., Mast cell mediators in tolerance. Curr. Opin. Immunol. 2010. 22: 643-648.
49. Brandt, E. B., Strait, R. T., Hershko, D., Wang, Q., Muntel, E. E., Scribner, T. A., Zimmermann, N. et al., Mast cells are required for experimental oral allergen-induced diarrhea. J. Clin. Invest. 2003. 112: 1666-1677.